$0.38
▲ +0.9% Today
as of Jul 22, 16:51 ET
Last 30 days
Recent Press Releases & News
Medicus Pharma CEO details Teverelix progress – ICYMI
Medicus Pharma advances Phase 2 study following FDA and IRB feedback
Medicus Pharma advances Teverelix Phase 2 study after FDA feedback, IRB approval
Overview
52-week range
$0.25
$3.69
4% of range
Avg surprise (last 3)
-55.0%
Avg reaction (last 2)
+5.6%
100% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Thu May 14, 2026 | Mar/2026 | $-0.31 | $-0.18 | -72.2% | +26.2% | +5.3% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-1.12 | — | — | — | — | financials |
| Mon Aug 11, 2025 | Jun/2025 | $-0.43 | $-0.39 | -10.3% | — | — | earnings |
| Mon May 12, 2025 | Mar/2025 | $-0.42 | $-0.23 | -82.6% | — | +5.9% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.24 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.21 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Mon Aug 10, 2026 | Jun/2026 | OTHER | -$0.14 | -$0.43 | +67.4% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-9M | — | $-15 | $-6M | $-5M | — | $-2M | $-2M |
| Net income | $-9M | — | $-21M | — | $-5M | — | $-2M | $-2M |
| EPS (diluted) | $-0.31 | — | $-1.12 | $-0.43 | $-0.42 | — | $-0.24 | $-0.21 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $6M | $9M | $9M | $10M | $4M | $4M | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $7M | $10M | $10M | $11M | $5M | $5M | — | — |
| Total assets | $7M | $10M | $10M | $12M | $6M | $6M | — | — |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $6M | $10M | $11M | $9M | $4M | $3M | — | — |
| Total equity | $1M | $-67,554 | $-910,126 | — | — | $3M | — | — |
Implied volatility — last 90 days
No IV snapshots yet for MDCX.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.